Handbook of Gynecologic Oncology (PDF)
(Sprache: Englisch)
While the medical literature abounds with information on gynecological cancer, this book winnows that volume of data into one manageable reference. In a practical and easy-to-use layout, the Handbook of Gynecologic Oncology, Second Edition provides a...
Leider schon ausverkauft
eBook
- Lastschrift, Kreditkarte, Paypal, Rechnung
- Kostenloser tolino webreader
Produktdetails
Produktinformationen zu „Handbook of Gynecologic Oncology (PDF)“
While the medical literature abounds with information on gynecological cancer, this book winnows that volume of data into one manageable reference. In a practical and easy-to-use layout, the Handbook of Gynecologic Oncology, Second Edition provides a comprehensive and concise guide to the diagnosis and management of gynecologic cancer, including breast and colon cancers. Edited and written by the faculty of the gynecologic oncology programs of MD Anderson Cancer Center and Memorial Sloan-Kettering Cancer Center, this second edition reviews and updates various chapters.
It includes a discussion of the new developments in management and a new chapter on germ cell and sex cord-stromal tumors. The text is aimed at fellows and residents in gynecologic oncology, radiation oncology and medical oncology as well as residents in obstetrics and gynecologic surgery and medicine. It will also be a handy guide for medical students and practicing physicians.
It includes a discussion of the new developments in management and a new chapter on germ cell and sex cord-stromal tumors. The text is aimed at fellows and residents in gynecologic oncology, radiation oncology and medical oncology as well as residents in obstetrics and gynecologic surgery and medicine. It will also be a handy guide for medical students and practicing physicians.
Lese-Probe zu „Handbook of Gynecologic Oncology (PDF)“
18 Gestational trophoblastic disease (S. 323-324) Carol A Aghajanian
The term gestational trophoblastic disease (GTD) applies to tumors that arise in the fetal chorion during pregnancy. They are unique among human malignancies in that the tumor arises in fetal tissue that is genetically foreign to the host. Gestational trophoblastic diseases include benign partial and complete hydatiform moles, persistent invasive or metastatic moles, placental-site trophoblastic tumors, and gestational choriocarcinomas. These tumors are of great interest because of the ability to cure them with chemotherapy, even in advanced stages of disease. Human chorionic gonadotropin (hCG), a tumor marker that accurately measures extent of disease, is produced by most of these tumors.
EPIDEMIOLOGY
The incidence of complete hydatidiform moles is estimated to be between 0.26 and 2.1 per 1000 pregnancies. There is an apparent twofold increased risk in Saudi Arabia and Japan compared with other populations. There appears to be an increased risk of hydatidiform moles for women at each end of the range of reproductive life. A prior hydatiform mole increases the risk of subsequent moles by approximately tenfold. Risk factors for the development of gestational choriocarcinoma are less well de.ned. A hydatiform mole in the prior pregnancy is the single greatest risk factor. As with complete hydatiform moles, the incidence appears to be increased at the extremes of reproductive age. In addition, there appears to be a twofold increase in non-Caucasians as compared with Caucasians.
HISTOLOGIC TYPES AND CLINICAL CHARACTERISTICS
Complete hydatiform moles are diploid conceptions of paternal origin. They are characterized by generalized diffuse hyperplasia of both cytotrophoblast and syncytiotrophoblast elements. Generalized edema of the chorionic villi with central cistern formation leads to a gross appearance classically described as a
... mehr
"bunch of grapes." Complete hydatiform moles are often evident clinically (large for dates) or sonographically because of these hydropic changes. An embryo is generally not seen. No fetal or nucleated red blood cells are seen, since embryonic resorption occurs prior to the development of a fetal circulation. Vaginal bleeding is the most common clinical presenting symptom. Anemia is often present. Theca lutein cysts are present in approximately one-quarter to one-third of patients. Preeclampsia and hyperemesis occur in approximately 25% of patients. Both theca lutein cysts and preeclampsia are associated with high hCG levels (usually 100,000 mlU/ml). Elevated thyroid hormone levels are frequently seen, but clinical hyperthyroidism is rare. Malignant sequelae following evacuation of a complete hydatiform mole occurs in approximately 20% of patients.
In most patients, the malignant sequelae is the diagnosis of invasive or persistent mole, although one-quarter to one-third of patients with malignant sequelae following a complete hydatiform mole will have gestational choriocarcinoma. Invasive hydatiform moles have the histopathologic features of complete hydatiform moles, but with invasion beyond the normal placental implantation site directly into the myometrium. They often penetrate the venous system. Venous penetration can lead to the development of vaginal and lung metastasis and symptoms of bleeding. Deep penetration can lead to uterine perforation. It is a dif.cult diagnosis to make on specimens derived from endometrial curettage, and as hysterectomies are done so infrequently in GTD, it is not a common diagnosis. In the spectrum of malignant potential, they are intermediate, between hydatiform moles and choriocarcinomas. Partial hydatiform moles are triploid conceptions. They have a more subtle histologic appearance. There is only focal, slight trophoblastic hyperplasia and focal, variable hydropic villi. There is scalloping of the villi with trophoblastic inclusions within chorionic villi.
The embryo survives longer than in complete hydatiform moles, usually approximately 8 weeks. Therefore, there is frequently either gross or microscopic evidence of a fetus. In addition, fetal red blood cells can be identi.ed within fetal vessels. Owing to both the presence of a fetus and the minimal hydropic changes in the villi, partial hydatiform moles can be easily underdiagnosed without histologic and/or cytogenetic studies. Clinically, patients have uterine sizes either small or appropriate for dates. Sonographic appearance is often that of missed or spontaneous abortion. Preevacuation hCG levels are usually low. Patients usually do not have theca lutein cysts. Malignant sequelae are uncommon, compared with complete hydatiform moles, and almost always consist of nonmetastatic postmolar GTD.
In most patients, the malignant sequelae is the diagnosis of invasive or persistent mole, although one-quarter to one-third of patients with malignant sequelae following a complete hydatiform mole will have gestational choriocarcinoma. Invasive hydatiform moles have the histopathologic features of complete hydatiform moles, but with invasion beyond the normal placental implantation site directly into the myometrium. They often penetrate the venous system. Venous penetration can lead to the development of vaginal and lung metastasis and symptoms of bleeding. Deep penetration can lead to uterine perforation. It is a dif.cult diagnosis to make on specimens derived from endometrial curettage, and as hysterectomies are done so infrequently in GTD, it is not a common diagnosis. In the spectrum of malignant potential, they are intermediate, between hydatiform moles and choriocarcinomas. Partial hydatiform moles are triploid conceptions. They have a more subtle histologic appearance. There is only focal, slight trophoblastic hyperplasia and focal, variable hydropic villi. There is scalloping of the villi with trophoblastic inclusions within chorionic villi.
The embryo survives longer than in complete hydatiform moles, usually approximately 8 weeks. Therefore, there is frequently either gross or microscopic evidence of a fetus. In addition, fetal red blood cells can be identi.ed within fetal vessels. Owing to both the presence of a fetus and the minimal hydropic changes in the villi, partial hydatiform moles can be easily underdiagnosed without histologic and/or cytogenetic studies. Clinically, patients have uterine sizes either small or appropriate for dates. Sonographic appearance is often that of missed or spontaneous abortion. Preevacuation hCG levels are usually low. Patients usually do not have theca lutein cysts. Malignant sequelae are uncommon, compared with complete hydatiform moles, and almost always consist of nonmetastatic postmolar GTD.
... weniger
Bibliographische Angaben
- Autoren: David Gershenson , Michael Bevers , Richard Barakat , William J Hoskins
- 2004, Englisch
- Verlag: Taylor & Francis Group Plc
- ISBN-10: 0203270150
- ISBN-13: 9780203270158
Abhängig von Bildschirmgröße und eingestellter Schriftgröße kann die Seitenzahl auf Ihrem Lesegerät variieren.
eBook Informationen
- Dateiformat: PDF
- Mit Kopierschutz
Sprache:
Englisch
Kopierschutz
Dieses eBook können Sie uneingeschränkt auf allen Geräten der tolino Familie lesen. Zum Lesen auf sonstigen eReadern und am PC benötigen Sie eine Adobe ID.
Kommentar zu "Handbook of Gynecologic Oncology"
0 Gebrauchte Artikel zu „Handbook of Gynecologic Oncology“
Zustand | Preis | Porto | Zahlung | Verkäufer | Rating |
---|
Schreiben Sie einen Kommentar zu "Handbook of Gynecologic Oncology".
Kommentar verfassen